A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Investigational Drug Gaining Traction Online
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are urged to message these accounts directly for source information, while also obtaining promotional offers.
Thriving Commerce on Messaging Platforms
Separately, a robust market exists on Telegram, where groups with numerous of members share comparison photos, administration instructions and assertions of next-day British shipping. Vendors market the substance there before directing customers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Professionals Voice Concerns
However, doctors and pharmacists have warned that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to users administering substances of uncertain source.
Several experts said the demand for retatrutide could be linked to the increasing price of licensed slimming products such as Mounjaro.
Regulatory Status and Implementation
Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Several influencers try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to fines, prosecution or prison.
Platform Response and Material Elimination
Based on TikTok, the service has taken down problematic material and prohibited associated hashtags and search suggestions. The company said it was dedicated to maintaining the service safe and allocating resources in enhancing enforcement strategies.
Digital Trading Activities
Research also found groups with up to 9,000 members selling retatrutide using the platform's built-in search feature, which functions like a online catalog. Entering “retatrutide” instantly displays groups with numerous of members, filled with photos of slimming results, positive testimonials and step-by-step instructions for mixing or injecting at home.
After minutes of joining one group, a vendor posted contact information, where most purchases take place. The vendor provided an guidebook and promised shipping within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about body mass, medical conditions or past usage.
Product Information and Pricing
Inside these groups, posts show dark colored parcels with postal service labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use pens usually priced at 160 pounds for 20mg. When questioned how much time a pen should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Security Actions
A representative for the messaging service said it regularly moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are injecting substances they cannot confirm. Even if the science behind this drug is sound, these digital products may not include what they claim,” said Jason Murphy, the head of pharmacy at Chemist4U.
A medical professional of an online medical service linked the increase in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained.
Her team has previously seen patients harmed by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”
Manufacturer Statement
A spokesperson from Eli Lilly stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may expose users to potentially significant health risks”.
